XLON
0RNP
Market cap142mUSD
, Last price
EUR
Name
Avantium NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Avantium N.V., a chemical technology firm based in the Netherlands, is dedicated to innovating and commercializing sustainable chemistry solutions. The company's operations are divided into three core segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It manufactures furandicarboxylic acid (FDCA), a key ingredient for polyethylene furanoate (PEF), as well as PEF itself, a plant-derived, recyclable plastic suitable for packaging. Avantium also offers catalyst testing systems, including the Flowrence platform for evaluating catalysts and adsorbents. Its services extend to providing R&D systems, various support services, and refinery catalyst testing. Moreover, the company is developing "Ray" technology to produce mono-ethylene glycol (MEG) from industrial sugars and "Dawn" technology, which converts non-food plant biomass into industrial sugars and lignin. Additionally, Avantium produces polyesters using plantMEG. The company was founded in 2000 and has its headquarters in Amsterdam, the Netherlands.
Key people
Edwin Moses
Independent Chairman of the Supervisory Board · since 2019
Tom van Aken
Chief Executive Officer, Member of the Management Board · since 2006
Gert-Jan Gruter
Chief Technology Officer · since 2004
Carmen Portocarero
General Counsel · since 2012
Managing Director - Avantium Renewable Polymers · since 2021
Steven Olivier
Managing Director - Avantium Catalysis · since 2015
Bart Welten
Chief Financial Officer, Member of the Management Board · since 2020
Independent Member of the Supervisory Board · since 2020
Margret Kleinsman
Independent Vice Chairman of the Supervisory Board · since 2020
G.E Schoolenberg
Independent Member of the Supervisory Board · since 2020
Nils Bjoerkman
Member of the Supervisory Board · since 2022
Michelle Jou
Independent Member of the Supervisory Board · since 2020
Headquarters & legal address
Zekeringstraat 29
Amsterdam 1014BV
NL
Amsterdam 1014BV
NL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||